TRIB
Trinity Biotech
TRIB
TRIB
79 hedge funds and large institutions have $191M invested in Trinity Biotech in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 30 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
43% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 30
94% less call options, than puts
Call options by funds: $1K | Put options by funds: $18K
Holders
79
Holding in Top 10
2
Calls
$1K
Puts
$18K
Top Buyers
| 1 | +$2.16M | |
| 2 | +$1.7M | |
| 3 | +$704K | |
| 4 |
PCA
Prospect Capital Advisors
Sausalito,
California
|
+$475K |
| 5 |
BCM
Breithorn Capital Management
New York
|
+$353K |
Top Sellers
| 1 | -$3.26M | |
| 2 | -$2.86M | |
| 3 | -$1.02M | |
| 4 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$945K |
| 5 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
-$904K |